Expected Utility Theory (EUT), the first axiomatic theory of risky choice, describes choices as a utility maximization process: decision makers assign a subjective value (utility) to each choice option and choose the one with the highest utility. The continuity axiom, central to Expected Utility Theory and its modifications, is a necessary and sufficient condition for the definition of numerical utilities. The axiom requires decision makers to be indifferent between a gamble and a specific probabilistic combination of a more preferred and a less preferred gamble. While previous studies demonstrated that monkeys choose according to combinations of objective reward magnitude and probability, a concept-driven experimental approach for assessing the axiomatically defined conditions for maximizing utility by animals is missing. We experimentally tested the continuity axiom for a broad class of gamble types in 4 male rhesus macaque monkeys, showing that their choice behavior complied with the existence of a numerical utility measure as defined by the economic theory. We used the numerical quantity specified in the continuity axiom to characterize subjective preferences in a magnitude-probability space. This mapping highlighted a trade-off relation between reward magnitudes and probabilities, compatible with the existence of a utility function underlying subjective value computation. These results support the existence of a numerical utility function able to describe choices, allowing for the investigation of the neuronal substrates responsible for coding such rigorously defined quantity. A common assumption of several economic choice theories is that decisions result from the comparison of subjectively assigned values (utilities). This study demonstrated the compliance of monkey behavior with the continuity axiom of Expected Utility Theory, implying a subjective magnitude-probability trade-off relation, which supports the existence of numerical utility directly linked to the theoretical economic framework. We determined a numerical utility measure able to describe choices, which can serve as a correlate for the neuronal activity in the quest for brain structures and mechanisms guiding decisions.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018892PMC
http://dx.doi.org/10.1523/JNEUROSCI.0955-20.2020DOI Listing

Publication Analysis

Top Keywords

continuity axiom
20
expected utility
16
utility theory
16
numerical utility
16
utility
14
existence numerical
12
utility maximization
8
axiom expected
8
decision makers
8
utility measure
8

Similar Publications

Article Synopsis
  • * Datopotamab deruxtecan (Dato-DXd) is a promising new treatment being tested for these patients, showing good anti-tumor effects and safety.
  • * The TROPION-Lung07 study is a Phase III trial evaluating the effectiveness of Dato-DXd combined with pembrolizumab (with or without chemotherapy) compared to the current standard treatment, focusing on progression-free and overall survival rates (NCT05555732).
View Article and Find Full Text PDF

Rationale Of The Trial: Although the use of engineered T cells in cancer immunotherapy has greatly advanced the treatment of hematological malignancies, reaching meaningful clinical responses in the treatment of solid tumors is still challenging. We investigated the safety and tolerability of IMA202 in a first-in-human, dose escalation basket trial in human leucocyte antigen A*02:01 positive patients with melanoma-associated antigen A1 (MAGEA1)-positive advanced solid tumors.

Trial Design: The 2+2 trial design was an algorithmic design based on a maximally acceptable dose-limiting toxicity (DLT) rate of 25% and the sample size was driven by the algorithmic design with a maximum of 16 patients.

View Article and Find Full Text PDF

Wheat is an essential food commodity cultivated throughout the world. However, this crop faces continuous threats from fungal pathogens, leaf rust (LR) and stripe rust (YR). To continue feeding the growing population, these major destructors of wheat must be effectively countered by enhancing the genetic diversity of cultivated germplasm.

View Article and Find Full Text PDF

A crisis in clinical research.

J Immunother Cancer

July 2024

Yale School of Medicine, New Haven, Connecticut, USA.

The clinical research pipeline is critical to ensuring continued development of novel treatments that can offer patients with cancer safe and effective options. Unfortunately, progress has slowed since the COVID-19 pandemic due to uncovered, systemic inefficiencies across critical processes. Towards initiating discussion on how to reinvigorate clinical research, the Society for Immunotherapy of Cancer (SITC) hosted a virtual summit that characterized issues and formed potential solutions.

View Article and Find Full Text PDF
Article Synopsis
  • Pamiparib, a selective inhibitor targeting certain cancer vulnerabilities, was tested in a study with temozolomide (TMZ) for treating advanced solid tumors in adults.
  • The study involved administering pamiparib alongside escalating doses of TMZ to find safe and effective dosing, while also monitoring for side effects and tumor response.
  • Results showed that while the combination had some modest effectiveness, the main side effects were anemia, nausea, and fatigue, with no reported treatment-related deaths.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!